1
Immunogenicity and Safety of Gardasil-9 and Cervarix
Condition(s):HPV Vaccines Immunogenicity and SafetyLast Updated:January 18, 2019Completed
GARDASIL 9: 88 Clinical Trials, Page 1 of 9
Hide Studies Not Open or Pending
2
Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9
Condition(s):Human Papillomavirus VaccinesLast Updated:February 13, 2018Completed
3
Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age
Condition(s):Cervical Cancer; Condylomata AcuminataLast Updated:April 8, 2021Active, not recruiting
4
Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Condition(s):Allogeneic Hematopoietic Stem Cell Transplant Recipient; Hematopoietic and Lymphoid Cell NeoplasmLast Updated:March 2, 2021Active, not recruiting
5
Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients
Condition(s):Human Papilloma Virus; Hiv; Organ TransplantsLast Updated:December 11, 2020Completed
6
Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial
Condition(s):NeoplasiaLast Updated:August 29, 2019Not yet recruiting
7
GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
Condition(s):Immunization; Efficacy; Human Papilloma VirusLast Updated:April 13, 2021Recruiting
8
Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)
Condition(s):Papillomavirus Infections; Uterine Cervical Neoplasms; Vulvar Neoplasms; Vaginal Neoplasms; Adenocarcinoma in Situ; Condylomata AcuminataLast Updated:February 25, 2020Completed
9
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Condition(s):HPV InfectionLast Updated:December 3, 2020Recruiting
10
Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia
Condition(s):Idiopathic CD4 T Cell LymphocytopeniaLast Updated:October 1, 2021Recruiting